Introduction
============

The major human pathogen *Streptococcus pneumoniae* colonizes the human nasopharynx and is the causal agent of many diseases, including pneumonia, sepsis, meningitis, and others. Pneumococcal nitrogen metabolism and regulation have been studied extensively as the appropriate acquisition and metabolism of nutrients are important for its lifestyle ([@B15]). Sulfur is an integral part of many essential components of the cell, such as cysteine, methionine, thiamine, biotin, lipoic acid, coenzyme A, etc. Among these compounds, cysteine plays a key role, as it is the most important sulfur-containing compound-forming metabolite and its *de novo* synthesis signifies the central pathway of sulfur acquisition in microorganisms and plants ([@B48]). Many important proteins (such as cytochromes and aconitase) also have cysteine as an essential amino acid in their catalytic domains. Moreover, cysteine (and the dimer cysteine) helps in protein folding, assembly and stability, being involved in the formation of disulfide bounds. Cysteine-derived proteins (such as thioredoxin and glutathione) help in countering oxidative stress ([@B48]). Methionine is another sulfur-containing amino acid, regulating the initiation of translation and is vital to several methyl-transferase reactions ([@B48]). Microorganisms can synthesize methionine by converting homoserine to homocysteine through addition of a sulfur group from either cysteine (requiring MetABC), sulfide (requiring MetA and CysD) or by using the SAM (*S*-adenosylmethionine) recycling pathway (MetK, Pfs, and LuxS) ([@B25]). Homocysteine is then methylated by methionine synthase (MetE) in conjunction with a methylenetetrahydrofolate reductase (MetF), with the methyl group supplied by 5-methyltetrahydrofolate, to form methionine ([@B25]).

Cysteine and methionine concentrations might be regulating bacterial growth in different conditions, such as pathogenic events or fermentation processes, as these amino acids have essential roles in metabolism ([@B41]). In *Brucella melitensis* ([@B28]), *Haemophilus parasuis* ([@B16]) and, *Salmonella enterica* ([@B11]), sulfur-containing amino acid biosynthesis genes have been characterized as virulence factors. The *cysDNC* operon involved in the sulfate activation pathway forms a stress-induced operon in *Mycobacterium tuberculosis* ([@B38]), whereas several thiol- and cysteine metabolism genes comprise the *sigH* regulon necessary for optimal existence of the bacterium in macrophages ([@B31]). Furthermore, cysteine metabolism also controls the regulation of toxin formation in *Bordetella pertussis* ([@B7]). Similarly, cysteine regulates a signaling molecule derivative of sulfur metabolism, autoinducer 2, which is conserved in both Gram-positive and -negative bacteria and is involved in interspecies communication and regulation of virulence factors ([@B49]; [@B35]).

Our current study elucidates the effect of cysteine on the global gene expression of *S. pneumoniae* and characterizes the role of the transcriptional regulator CmbR in regulation of *spd-0150*, *metEF*, *gshT*, *spd-0618*, *tcyB*, *metA*, and *yvdE*. The transcriptional regulator CmbR acts as a transcriptional repressor for a number of genes/operons involved in cysteine uptake and utilization. The putative operator site (5′-GYGATAAAAAWWAYTTATMAC-3′ where Y = T/C, W = A/T and M = A/C) of CmbR in the promoter regions of *spd-0150*, *metEF*, *gshT*, *spd-0618*, *tcyB*, *metA*, and *yvdE* is predicted and confirmed by promoter mutational/deletion experiments. Moreover, this site is found highly conserved in other pneumococcal strains and streptococci.

Materials and Methods {#s1}
=====================

Bacterial Strains and Growth Conditions
---------------------------------------

Bacterial strains and plasmids used in this study are listed in **Table [1](#T1){ref-type="table"}**. *S. pneumonia*e D39 was grown as described previously ([@B21]; [@B4]). For β-galactosidase assays, derivatives of *S. pneumoniae* D39 were grown in a chemically defined medium (CDM) ([@B23]) supplemented either with 0.03 or 50 mM cysteine. CDM was prepared without cysteine. For selection on antibiotics, the medium was supplemented with the following concentrations of antibiotics: tetracycline: 2.5 μg/ml for *S. pneumoniae*; ampicillin: 100 μg/ml for *Escherichia coli* and erythromycin: 0.25 μg/ml for *S. pneumoniae* and 120 μg/ml for *E. coli*. All bacterial strains used in this study were stored in 10% (v/v) glycerol at -80°C. For PCR amplification, chromosomal DNA of *S. pneumoniae* D39 ([@B26]) was used as a template. Primers used in this study are based on the sequence of the *S. pneumoniae* D39 genome and are listed in **Table [2](#T2){ref-type="table"}**.

###### 

List of strains and plasmids used in this study.

  Strain/plasmid        Description                                                                                                      Source
  --------------------- ---------------------------------------------------------------------------------------------------------------- ---------------------------
  ***S. pneumoniae***                                                                                                                    
  D39                   Serotype 2 strain. *2*                                                                                           Laboratory of P. Hermans.
  MA1000                D39 Δ*cmbR*                                                                                                      This study
  MA1101                D39 Δ*bgaA*:: P*spd-0150-lacZ*; Tet^R^                                                                           [@B1]
  MA1104                D39 Δ*bgaA*:: P*metE-lacZ*; Tet^R^                                                                               [@B1]
  MA1105                D39 Δ*bgaA*:: P*gshT-lacZ*; Tet^R^                                                                               [@B1]
  MA1106                D39 Δ*bgaA*:: P*spd-0618-lacZ*; Tet^R^                                                                           [@B1]
  MA1109                D39 Δ*bgaA*:: P*tcyB-lacZ*; Tet^R^                                                                               [@B1]
  MA1110                D39 Δ*bgaA*:: P*metA-lacZ*; Tet^R^                                                                               [@B1]
  MA1001                D39 Δ*bgaA*:: P*yvdE-lacZ*; Tet^R^                                                                               This study
  MA1002                MA1000 Δ*bgaA*:: P*spd-0150-lacZ*; Tet^R^                                                                        This study
  MA1114                MA1000 Δ*bgaA*:: P*metE-lacZ*; Tet^R^                                                                            This study
  MA1003                MA1000 Δ*bgaA*:: P*gshT-lacZ*; Tet^R^                                                                            This study
  MA1004                MA1000 Δ*bgaA*:: P*spd-0618-lacZ*; Tet^R^                                                                        This study
  MA1005                MA1000 Δ*bgaA*:: P*tcyB-lacZ*; Tet^R^                                                                            This study
  MA1006                MA1000 Δ*bgaA*:: P*metA-lacZ*; Tet^R^                                                                            This study
  MA1007                MA1000 Δ*bgaA*:: P*yvdE-lacZ*; Tet^R^                                                                            This study
  MA1008                D39 Δ*bgaA*:: P*spd-0150-M-lacZ*; Tet^R^                                                                         This study
  MA1009                D39 Δ*bgaA*:: P*spd-metE-M-lacZ*; Tet^R^                                                                         This study
  MA1010                D39 Δ*bgaA*:: P*spd-0618R1-M-lacZ*; Tet^R^                                                                       This study
  MA1011                D39 Δ*bgaA*:: P*spd-0618R2-M-lacZ*; Tet^R^                                                                       This study
  MA1012                D39 Δ*bgaA*:: P*metA-TER-lacZ*; Tet^R^                                                                           This study
  ***E. coli***                                                                                                                          
  EC1000                Km^R^; MC1000 derivative carrying a single copy of the pWV1 *repA* gene in *glgB*                                Laboratory collection
  **Plasmids**                                                                                                                           
  pPP2                  Amp^R^ Tet^R^; promoter-less *lacZ*. For replacement of *bgaA* with promoter *lacZ* fusion. Derivative of pPP1   [@B14]
  pORI280               Erm^R^; *ori^+^ repA^-^;* deletion derivative of pWV01; constitutive *lacZ* expression from P32 promoter         [@B27]
  pMA1000               pORI280 carrying *cmbR* deletion                                                                                 This study
  pMA1101               pPP2 P*spd-0150-lacZ*                                                                                            [@B1]
  pMA1104               pPP2 P*metE-lacZ*                                                                                                [@B1]
  pMA1105               pPP2 P*gshT-lacZ*                                                                                                [@B1]
  pMA1106               pPP2 P*spd-0618-lacZ*                                                                                            [@B1]
  pMA1109               pPP2 P*tcyB-lacZ*                                                                                                [@B1]
  pMA1110               pPP2 P*metA-lacZ*                                                                                                [@B1]
  pMA1001               pPP2 P*yvdE-lacZ*                                                                                                This study
  pMA1002               pPP2 P*spd-0150-M-lacZ*                                                                                          This study
  pMA1003               pPP2 P*metE-M-lacZ*                                                                                              This study
  pMA1004               pPP2 P*spd-0618R1-M-lacZ*                                                                                        This study
  pMA1005               pPP2 P*spd-0618R2-M-lacZ*                                                                                        This study
  pMA1006               pPP2 P*metA-TER-lacZ*                                                                                            This study

###### 

List of primers used in this study.

  Name                 Nucleotide Sequence (5′-3′)                                                     Restriction site
  -------------------- ------------------------------------------------------------------------------- ------------------
  spd-0150-M-F         CATG[GAATTC]{.ul}GGTCTTTTAAATTACCCGCGAAAAAAACTTATCA                             *EcoRI*
  spd-0150-R           CATG[GGATCC]{.ul}GGCAGCAAGAGATGAGTAT                                            *BamHI*
  metE-M-F             CATG[GAATTC]{.ul}ATCAGTTATAGTCTTTTCTAATAACAAGCCATAGTCACTTGCAAGAATTACTAGCAACGC   *EcoRI*
  metE-R               CATG[GGATCC]{.ul}GTTGACATGATGTGTCCTCC                                           *BamHI*
  spd-0618-M-R1-F      CATG[GAATTC]{.ul}ATGTCTATGGCCAAAAATCCTGCGAAC                                    *EcoRI*
  spd-0618-M-R2-F      CATG[GAATTC]{.ul}ATGTCTATGGTAAAAAATCCTTATAACGGCAGCGAAAAATAGAGCGTAT              *EcoRI*
  spd-0618-R           CATG[GGATCC]{.ul}GTTCAACAATGGACCAATCC                                           *BamHI*
  metA-CmbR-TER        CATG[GAATTC]{.ul}GTTAGAGAAAAACTATAATTGAA                                        *EcoRI*
  metA-CmbR-TER        CATG[GAATTC]{.ul}GTTAGAGAAAAACTATAATTGAAAATTGTGTCT                              *EcoRI*
  metA-R               CATG[GGATCC]{.ul}GCACGTTGATCATCCATGAC                                           *BamHI*
  yvdE-F               CATG[GAATTC]{.ul}GTCATTGAACGTGGTAACC                                            *EcoRI*
  yvdE-R               CATG[GGATCC]{.ul}CATAGATTTGCAGCAACTCC                                           *BamHI*
  CmbR-1               TGCTCTAGACATTTATGCTAGTGGAGG                                                     *XbaI*
  CmbR-2               CCACTATTGGCAATAGCC                                                              *--*
  CmbR-3               CTATTGCCAATAGTGGCTCTTCGTAGAAGTCATGC                                             *--*
  CmbR-4               GAAGATCTCCGTCAGATAGCTATCTGCC                                                    *BglII*
  **RT-PCR primers**                                                                                   
  gyrA-F               CGAGGCACGTATGAGCAAGA                                                            --
  gyrA-R               GACCAAGGGTTCCCGTTCAT                                                            --
  spd-0150-1           GCGGCTTGCTCAGGGGG                                                               --
  spd-0150-2           CCAGCAAAGACACCTGACC                                                             --
  metQ-1               GCTACAGTCGCAGGTTTGGC                                                            --
  metQ-2               CTTCGCCATCAGCAGTTGC                                                             --
  spd-0431-1           GGTCTGGTTGATGGTGCGG                                                             --
  spd-0431-2           CCAGTAATCCACCGTCTG                                                              --
  metE-1               GGCATCACTGAAATCCC                                                               --
  metE-2               GGTAACCACGTCCCAAAGCG                                                            --
  metF-1               CCGTCACTCTCATTTGAAG                                                             --
  metF-2               GGCAAGTGGGCAATGGTCG                                                             --
  gshT-1               CGTGCCACCATTTGACTACG                                                            --
  gshT-2               GCAGCCTGATAGTGACC                                                               --
  spd-0618-1           CGTTAGTATCATCCGAC                                                               --
  spd-0618-2           GATTCTGCCATATAGGAG                                                              --
  fhs-1                CAGATATTGAAATCGCACAG                                                            --
  fhs-2                GCCTTGTACTTTCCGTAC                                                              --
  Csd-1                CGTTTAGGGCACCATACC                                                              --
  Csd-2                GTCTTCACTGGCATAGG                                                               --
  metB-1               GTCAGATGAAGCGACAGG                                                              --
  metB-2               GCCAAGACTTCCTCAGCC                                                              --
  metA-1               GGCTAATACACCCCTACA                                                              --
  metA-2               CCTCAAATGGTAAATGCTC                                                             --
  spd-1898-1           GGAACATCTGGTCGTTC                                                               --
  spd-1898-2           CTATCATAACGCTTACC                                                               --
  yvdE-1               GGCTAGAACGGTTGTAGG                                                              --
  yvdE-2               CTGACTCATCACCAACAGG                                                             --
  cysK-1               CATCGTGCCAGAAGGTGC                                                              --
  cysK-2               CCTTTAGCAGCACCTACC                                                              --

Construction of a *cmbR* Mutant
-------------------------------

A markerless *cmbR* mutant (MA1000) was constructed in *S. pneumoniae* D39 using pORI280, as described before ([@B21]). Primer pairs cmbR-1/cmbR-2 and cmbR-3/cmbR-4 were used to generate PCR fragments of the left and right flanking regions of *cmbR*. The integrity of the *cmbR* mutant (MA1000) was further confirmed by PCR and DNA sequencing.

Construction of Promoter *lacZ*-Fusions and β-Galactosidase Assays
------------------------------------------------------------------

Chromosomal transcriptional *lacZ*-fusions to the *spd-0150*, *metE*, *gshT*, *spd-0618*, *tcyB*, *metA*, and *yvdE* promoters were constructed in our previous study ([@B1]). These constructs were further introduced into the D39 Δ*cmbR* (MA1000) strain resulting in strains MA1002-06, respectively. Transcriptional *lacZ*-fusion to the *yvdE* promoter was constructed in pPP2 ([@B14]) with primer pairs mentioned in **Table [2](#T2){ref-type="table"}** resulting in pMA1001. This construct was further introduced into the D39 wild-type and the D39 Δ*cmbR* (MA1000) strains resulting in strains MA1001 and MA1007, respectively. The following sub-clones of P*spd-0150*, P*metE*, P*spd-0618*, and P*metA* were made in pPP2 ([@B14]) using the primer pairs mentioned in **Table [2](#T2){ref-type="table"}**: P*spd-0150-M* (mutation in the *cmbR* site), P*metE-M* (mutation in the *cmbR* site), P*spd-0618R1-M* (mutation in the *cmbR* site 1), P*spd-0618R2-M* (mutation in the *cmbR* site 2), and P*metA*-*TER* (termination of the *cmbR* site), resulting in plasmids pMA1002-06, respectively. These constructs were introduced into the *S. pneumoniae* D39 wild-type, resulting in strains MA1008-12, respectively. All plasmid constructs were checked for the presence of the insert by PCR and DNA sequencing.

β-galactosidase assays were performed as described before ([@B18]; [@B14]) using cells that were harvested in the mid-exponential growth phase, and grown in CDM supplemented either with 0.03 or 50 mM cysteine.

Microarray Analysis
-------------------

Microarray analysis was performed as described before ([@B2]; [@B43]). For DNA microarray analysis of *S. pneumoniae* in the presence of cysteine, the transcriptomes of *S. pneumoniae* D39 wild-type, grown in replicates in CDM with 0.03 mM cysteine, was compared to that grown in CDM with 50 mM cysteine and harvested at respective mid-exponential growth phases. For the identification of differentially expressed genes, a Bayesian *p*-value of \<0.001 and a fold-change cut-off \>1.5 was applied. RNA isolation was performed as described before ([@B2]). All other procedures regarding the DNA microarray experiments and data analysis were performed as previously described ([@B44],[@B45]; [@B3]). Microarray data have been submitted to GEO under the accession number GSE89458.

Reverse Transcription (RT)-PCR and Purification for Quantitative RT-PCR
-----------------------------------------------------------------------

For quantitative RT-PCR, *S. pneumoniae* D39 wild-type and D39 Δ*cmbR* were grown in replicates in CDM supplemented with either 0.03 mM or 50 mM cysteine. RNA isolation was done as described before ([@B2]). First, strand cDNA synthesis was performed on RNA ([@B45]). cDNA (2 μl) was amplified in a 20 μl reaction volume that contained 3 pmol of each primer (**Table [2](#T2){ref-type="table"}**) and the reactions were performed in three technical replicates on two biological replicates of RNA ([@B45]). The transcription level of specific genes was normalized to *gyrA* transcription, amplified in parallel with gyrA-F and gyrA-R primers. The results were interpreted using the comparative CT method ([@B42]). Differences in expression of twofold or greater relative to control were considered as significant.

Results
=======

Cysteine-Dependent Gene Regulation in *S. pneumoniae* D39
---------------------------------------------------------

Cysteine is one of the most important amino acids for bacteria. It is also present in human blood plasma at concentration of 0.03 mM ([@B29]). To study the impact of cysteine on the transcriptome of *S. pneumoniae* D39 wild-type, we performed microarray comparison of *S. pneumoniae* D39 grown in CDM with 0.03--50 mM cysteine. 0.03 mM concentration was chosen, as this is the concentration of cysteine in human blood plasma ([@B29]). 50 mM concentration of cysteine is normally used to prepare CDM. A number of genes/gene clusters were differentially regulated under our tested conditions (**Table [3](#T3){ref-type="table"}**). The expression of *spd-0447-49* and *spd-1098-99* was altered under our tested conditions. These genes belong to the glutamine regulon and their expression has been reported to be downregulated in the presence of a nitrogen source ([@B22]). The expression of important metal-related genes (*prtA*, *psaBC* and *spd-1402*) was downregulated under our tested conditions. These genes belong to the PsaR regulon and repressed by transcriptional regulator PsaR in the presence of manganese ([@B19]). These genes have been shown to have role in virulence of pneumococcus ([@B24]). Therefore, it might be interesting to further explore the role of cysteine in the regulation of these genes.

###### 

Summary of transcriptome comparison of *S. pneumoniae* D39 wild-type grown in CDM with 0.03 mM cysteine to grown in CDM with 50 mM cysteine.

  D39 tag^a^                Function^b^                                                                       Ratio^c^
  ------------------------- --------------------------------------------------------------------------------- ----------
  **Upregulated genes**                                                                                       
  *spd_0145*                Hypothetical protein                                                              2.8
  *spd_0146*                CAAX amino terminal protease family protein                                       2.2
  *spd_0147*                CAAX amino terminal protease family protein                                       2.6
  *spd_0148*                Transporter, major facilitator family protein                                     1.8
  *spd_0150*                ABC transporter, substrate-binding protein                                        7.2
  *spd_0151*                Lipoprotein, MetQ                                                                 4.5
  *spd_0152*                Peptidase, M20/M25/M40 family protein                                             2.0
  *spd_0153*                ABC transporter, ATP-binding protein                                              2.0
  *spd_0154*                ABC transporter, permease protein, putative                                       1.6
  *spd_0373*                Hypothetical protein                                                              3.2
  *spd_0431*                Hypothetical protein                                                              1.5
  *spd_0510*                5-methyltetrahydropteroyltriglutamate--homocysteine *S*-methyltransferase, MetE   8.3
  *spd_0511*                5,10-methylenetetrahydrofolate reductase, MetF                                    7.9
  *spd_0540*                Amino acid ABC transporter, amino acid-binding protein, putative, GshT            4.8
  *spd_0615*                ABC transporter substrate-binding protein, authentic truncation                   3.2
  *spd_0616*                Amino acid ABC transporter, ATP-binding protein                                   1.9
  *spd_0617*                Amino acid ABC transporter, permease protein                                      2.0
  *spd_0618*                Amino acid ABC transporter, permease protein                                      1.6
  *spd_1073*                *O*-acetylhomoserine aminocarboxypropyltransferase/cysteine synthase              1.6
  *spd_1074*                Hypothetical protein                                                              1.5
  *spd_1290*                Cystine ABC transporter, permease protein, TcyB                                   1.5
  *spd_1352*                Aminotransferase, class II, Csd                                                   2.3
  *spd_1353*                Cys/Met metabolism PLP-dependent enzyme, putative, MetB                           1.6
  *spd_1406*                Homoserine *O*-succinyltransferase, MetA                                          1.7
  *spd_1898*                Hypothetical protein                                                              4.5
  *spd_1899*                Glutamine amidotransferase, class 1, YvdE                                         6.9
  *spd_2037*                Cysteine synthase A, CysK                                                         3.7
  **Downregulated genes**                                                                                     
  *spd_0447*                Transcriptional regulator, GlnR                                                   -2.1
  *spd_0448*                Glutamine synthetase, GlnA                                                        -2.7
  *spd_0449*                Hypothetical protein                                                              -1.5
  *spd_0558*                Cell wall-associated serine protease, PrtA                                        -4.4
  *spd_1098*                Amino acid ABC transporter, GlnP                                                  -1.9
  *spd_1099*                Amino acid ABC transporter, GlnQ                                                  -2.0
  *spd_1402*                Non-heme iron-containing ferritin                                                 -2.6
  *spd_1461*                Manganese ABC transporter, ATP-binding protein, PsaB                              -4.0
  *spd_1462*                Manganese ABC transporter, permease protein, putative, PsaC                       -4.0
  *spd_1463*                ABC transporter, substrate binding lipoprotein                                    -4.0

a

Gene numbers refer to D39 locus tags.

b

D39 annotation/TIGR4 annotation (

Lanie et al., 2007

),

c

Ratio represents the fold increase/decrease in the expression of genes in CDM with 0.03 mM cysteine to CDM with 50 mM cysteine. Errors in the ratios never exceeded 10% of the given values

.

The expression of putative methionine/cysteine transport and biosynthesis pathway genes (*spd-0150*, *metQ*, *spd-0431*, *metEF*, *gshT*, *spd-0618*, *fhs, tcyB*, *metB*-*csd*, *metA*, *spd-1898*, *yvdE*, and *cysK*) was significantly upregulated in the presence of 0.03 mM cysteine. The role of methionine in regulation of these genes has been demonstrated in our recent study ([@B1]). Furthermore, we showed that a transcriptional regulator CmhR acts as a transcriptional activator of *fhs*, *folD*, *metB*, *metEF*, *metQ*, and *spd-0431*. However, regulatory mechanism of *spd-0150*, *gshT*, *spd-0618*, *tcyB*, *metA*, *spd-1898*, *yvdE*, and *cysK* is not explored. Therefore, we decided to further explore the role of cysteine in the regulation of these genes.

Confirmation of Cysteine-Dependent Expression of *spd-0150*, *metQ*, *spd-0431*, *metEF*, *gshT*, *spd-0618*, *fhs, tcyB*, *metB*-*csd*, *metA*, *spd-1898*, *yvdE*, and *cysK*
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

To confirm our microarray results and to study the expression of *spd-0150*, *metQ*, *spd-0431*, *metEF*, *gshT*, *spd-0618*, *fhs, tcyB*, *metB*-*csd*, *metA*, *spd-1898*, *yvdE*, and *cysK* under limiting cysteine concentration in CDM, we performed quantitative RT-PCR on these genes. Our quantitative RT-PCR results demonstrated that the expression of these genes was increased significantly in CDM with 0.03 mM cysteine, when compared to 50 mM (**Figure [1](#F1){ref-type="fig"}**). These data not only confirms our microarray results mentioned above, but also suggests a direct role of these genes in cysteine transport and biosynthesis.

![**The relative increase in the expression of *spd-0150*, *metQ*, *spd-0431*, *metEF*, *gshT*, *spd-0618*, *fhs, tcyB*, *metB*-*csd*, *metA*, *spd-1898*, *yvdE*, and *cysK* in *S. pneumoniae* D39 wild-type grown in CDM with 0.03 mM cysteine compared to that grown in CDM with 50 mM cysteine.** The expression of these genes was normalized with housekeeping gene *gyrA*.](fmicb-07-01929-g001){#F1}

There are three LysR-type transcriptional regulators in different bacteria, which have been shown to be involved in the regulation of sulfur amino acids ([@B48], [@B47]). *S. pneumoniae* also has two LysR-type transcriptional regulators (CmhR and CmbR), which are proposed to be involved in the regulation of the sulfur amino acids ([@B37]). Our recent study has revealed the regulatory mechanism of CmhR in *S. pneumoniae* and demonstrates that CmhR acts as a transcriptional activator of the *fhs*, *folD*, *metB*-*csd*, *metEF*, *metQ*, and *spd-0431* in the presence of methionine ([@B1]). The presence of CmbR (putative Cysteine Methionine Biosynthesis Regulator) in *S. pneumoniae* suggests its involvement in the regulation of cysteine-responsive genes. Therefore, we decided to further study the role of transcriptional regulator CmbR in the regulation of cysteine transport and biosynthesis genes.

Prediction of the CmbR Regulatory Site and the Role of CmbR as a Transcriptional Repressor of *spd-0150*, *metEF*, *gshT*, *spd-0618*, *tcyB*, *metA*, and *yvdE*
-----------------------------------------------------------------------------------------------------------------------------------------------------------------

The presence of *cmbR* in the *S. pneumoniae* genome suggests its involvement in the regulation of cysteine-responsive genes. *cmbR* codes for the putative transcriptional regulator CmbR, which belongs to the LysR family of proteins. CmbR is a homolog of a LysR-type regulator (also called FhuR) of *Lactococcus lactis* and *Streptococcus mutans* ([@B12]; [@B48], [@B47]). To study the role of CmbR in *S. pneumoniae* D39, we analysed the promoter regions of cysteine-regulated genes and predicted a 21-bp palindromic-like sequence (that has high homology with the FhuR binding site of *L. lactis* and *S. mutans*) in the promoter regions of *spd-0150*, *metEF*, *gshT*, *spd-0618*, *tcyB*, *metA*, and *yvdE* indicating that CmbR regulon in *S. pneumoniae* D39 is comprised of these genes. This DNA sequence might serve as the CmbR operator site in *S. pneumoniae*. The CmbR site present in the promoter regions of *spd-0150*, *metEF*, *gshT*, *spd-0618*, *tcyB*, *metA*, and *yvdE* is shown in **Figure [2A](#F2){ref-type="fig"}**. A weight matrix of these CmbR sites (5′-GYGATAAAAAWWAYTTATMAC-3′) was constructed (**Figure [2B](#F2){ref-type="fig"}**). Promoter regions of these genes were also examined in other streptococcal species (*Streptococcus mitis*, *Streptococcus agalactiae*, *Streptococcus gallolyticus*, *Streptococcus gordonii*, *S. mutans*, *Streptococcus sanguinis*, *Streptococcus suis*, and *Streptococcus thermophilus*) to check whether the CmbR site is also conserved in those streptococci. The CmbR site is highly conserved in these streptococci as well. Moreover, we constructed a phylogenetic tree of CmbR present in different streptococci, which shows that it is highly conserved in these streptococci (**Figure [3](#F3){ref-type="fig"}**).

![**Identification of the CmbR operator site. (A)** Weight matrix of the identified CmbR operator site in the promoter region of *spd-0150*, *metEF*, *gshT*, *spd-0618*, *tcyB*, *metA*, and *yvdE*. **(B)** Position of the CmbR operator site in the promoter region of *spd-0150*, *metEF*, *gshT*, *spd-0618*, *tcyB*, *metA*, and *yvdE*. Translational start sites are italic and putative CmbR operator sites are bold and underlined.](fmicb-07-01929-g002){#F2}

![**A phylogenetic tree of CmbR in different streptococci showing conservation of CmbR in these streptococci**.](fmicb-07-01929-g003){#F3}

To investigate the role of CmbR in the regulation of *spd-0150*, *metEF*, *gshT*, *spd-0618*, *tcyB*, *metA*, and *yvdE*, we performed β-galactosidase assays with the promoter *lacZ*-fusions that were constructed in the *S*. *pneumoniae* D39 wild-type and D39 *ΔcmhR* in CDM with 50 mM cysteine. We used CDM with 50 mM cysteine, because we assumed the role of CmbR as a transcriptional repressor of these genes in the presence of cysteine. The results of the β-galactosidase assays showed that the activity of P*spd-0150*-*lacZ*, P*metE*-*lacZ*, P*gshT*-*lacZ*, P*spd-0618*-*lacZ*, P*tcyB*-*lacZ*, P*metA*-*lacZ*, and P*yvdE*-*lacZ* increased significantly in D39 *ΔcmbR* compared to D39 wild-type in CDM with 50 mM cysteine (**Figure [4](#F4){ref-type="fig"}**). Increased expression of these promoters in D39 *ΔcmbR* indicates the role of CmbR as a transcriptional repressor of *spd-0150*, *metEF*, *gshT*, *spd-0618*, *tcyB*, *metA*, and *yvdE*.

![**Expression levels (in Miller units) of P*spd-0150-lacZ*, P*metE-lacZ*, P*gshT-lacZ*, P*spd-0618-lacZ*, P*tcyB-lacZ*, P*metA-lacZ*, and P*yvdE*-*lacZ* in CDM with 50 mM cysteine in *S. pneumoniae* D39 wild-type and D39 Δ*cmbR***.](fmicb-07-01929-g004){#F4}

Confirmation of CmbR-Dependent Expression of *spd-0150*, *metEF*, *gshT*, *spd-0618*, *tcyB*, *metA*, and *yvdE*
----------------------------------------------------------------------------------------------------------------

To further confirm the role of CmbR as a transcriptional repressor of *spd-0150*, *metEF*, *gshT*, *spd-0618*, *tcyB*, *metA*, and *yvdE*, we performed quantitative RT-PCR on these genes in the presence of 50mM cysteine. Our quantitative RT-PCR results demonstrated that the expression of *spd-0150*, *metEF*, *gshT*, *spd-0618*, *tcyB*, *metA*, and *yvdE* increased significantly in D39 *ΔcmbR* compared to the D39 wild-type (**Figure [5](#F5){ref-type="fig"}**). These data provide further confirmation of our results that CmbR acts as a transcriptional repressor of *spd-0150*, *metEF*, *gshT*, *spd-0618*, *tcyBC*, *metA*, and *yvdE*.

![**The relative increase in the expression of *spd-0150*, *metEF*, *gshT*, *spd-0618*, *tcyB*, *metA*, and *yvdE* in *S. pneumoniae* D39 Δ*cmbR* compared to D39 wild-type grown in CDM with 50 mM cysteine.** The expression of these genes was normalized with that of housekeeping gene *gyrA*.](fmicb-07-01929-g005){#F5}

Confirmation of a CmbR Operator Site in CmbR-Regulated Genes
------------------------------------------------------------

To verify the functionality of the predicted CmbR operator site present in the promoter regions of the CmbR regulated genes (*spd-0150*, *metEF*, *gshT*, *spd-0618*, *tcyBC*, *metA*, and *yvdE*), we made transcriptional *lacZ***-**fusions of P*spd-0150*, P*metE*, P*spd-0618*, and P*metA*, where conserved bases in the *cmbR* sites were mutated in P*spd-0150* (5′-CCC**[ATA]{.ul}**AAAAAAACTTATCAC-3′ to 5′-CCC**[GCG]{.ul}**AAAAAAACTTATCAC-3′), P*metE* (5′-CTT**[AT]{.ul}**AAGAATTACTA**[AT]{.ul}**AAC-3′ to 5′-CTT**[GC]{.ul}**AAGAATTACTA**[GC]{.ul}**AAC-3′), P*spd-0618* (R1: 5′-ATGG**[TA]{.ul}**AAAAATCCT**[TAT]{.ul}**AAC-3′ to 5′-ATGG**[CC]{.ul}**AAAAATCCT**[GCG]{.ul}**AAC-3′ and R2: 5′-GCA**[ATA]{.ul}**AAAAATAGA**[TAT]{.ul}**TAT-3′ to 5′-GCA**[GCG]{.ul}**AAAAATAGA**[GCG]{.ul}**TAT-3′), and terminated in P*metA* (CmbR site is deleted), and β-galactosidase assays were performed on cells grown in CDM with 50 mM cysteine. β-galactosidase assays data revealed that mutating the CmbR operator site in P*spd-0150* and P*metE*, and deletion of the CmbR operator site in P*metA* led to significantly increased expression of these promoter *lacZ***-**fusions in the presence of 50 mM cysteine (**Figure [6](#F6){ref-type="fig"}**). These data confirm that the predicted CmbR sites present in the promoter regions of these genes are functional and intact in *S. pneumoniae* D39. Two putative operator sites of CmbR are present in P*spd-0618* (R1 and R2). We mutated both sites individually. We could only observe derepression (caused by CmbR) of P*spd-0618* when operator site 1 (R1) was mutated and did not witness any change in the activity of P*spd-0618* due to mutations in operator site 2 (R2). This suggests that only operator site 1 (R1) is a functional operator site for CmbR in P*spd-0618*.

![**Expression levels (in Miller units) of mutated/terminated and non-mutated CmbR sites in P*spd-0150-lacZ*, P*metEF-lacZ*, P*spd-0618-lacZ*, and P*metA-TER-lacZ* in *S. pneumoniae* D39 wild-type grown in CDM with 50 mM cysteine**.](fmicb-07-01929-g006){#F6}

Discussion
==========

The sulfur-containing amino acids cysteine and methionine play essential role in various metabolic processes in the cell, especially because of their sulfur group, which plays a vital role in the catalytic sites of many enzymes and participates in ion- and redox metabolism ([@B5]). Involvement of multiple mechanisms in the regulation of these pathways in various groups of bacteria makes the regulatory phenomenon even more interesting, as it seems to evolve faster than that of many other regulatory pathways ([@B12]; [@B48], [@B47]). CmbR regulates most of the cysteine and methionine genes in *L. lactis*, where it binds to a 13-bp box centered 46--53 bp upstream of transcriptional start sites, with a second box with a same consensus sequence is located upstream of the first binding box (separated by 8--10 bp) ([@B12]; [@B13]; [@B48]). In other members of the closely related Streptococcaceae family, the existence of a different motif upstream of several potential cysteine genes ([@B25]) suggests that the regulation of sulfur amino acid metabolism may be diverse. In this study, we studied the cysteine-dependent gene expression and the role of CmbR in *S. pneumoniae* D39, and demonstrated that CmbR acts as a transcriptional repressor of *spd-0150*, *metEF*, *gshT*, *spd-0618*, *tcyB*, *metA*, and *yvdE*.

The number of transcriptional factors regulating cysteine/methionine genes varies among different bacteria. This number is three in *S. mutans* (MetR, CysR and HomR), where these transcriptional regulators are phylogenetically related ([@B47]). CysR activates the transcription of *cysK* (codes for the cysteine biosynthesis enzyme), *tcyABC*, *gshT* (code for the cysteine and glutathione transporter systems), and *homR*. HomR is needed for the activation of *metBC* (code for the methionine biosynthesis enzymes), *tcyDEFGH* (involved in cysteine transport) and thiosulfate metabolism genes. Control of HomR by CysR emulates a cascade regulation for sulfur amino acid metabolism in *S. mutans*. Similarly, MtaR has been found to have a role in the regulation of the cysteine/methionine metabolism in *S. agalactiae* ([@B46]). MetJ and MetR, regulate the expression of methionine biosynthetic genes in *E. coli* and *S. enterica* serovar Typhimurium ([@B50]). The *E. coli met* genes (except for *metH*) are negatively regulated by MetJ, a transcriptional repressor, with SAM (S-adenosylmethionine) serving as a co-repressor ([@B40]). These genes are also under the positive influence of a LysR-type transcriptional regulator MetR, with homocysteine as a co-effector ([@B8]; [@B34]; [@B9]). CmbR in *L. lactis* also activates most genes involved in the methionine and cysteine biosynthesis pathway in the absence of cysteine ([@B48]). The regulatory proteins mentioned above belong to LysR family of transcription factors, which is the most abundant family of regulators in bacteria ([@B30]). These regulators control diverse biological pathways such as central metabolism, cell division, quorum sensing, virulence, motility, nitrogen fixation, oxidative stress responses, toxin production, attachment, and secretion. These transcriptional regulators act as either activators or repressors, and often are transcribed divergently with one of the regulated genes ([@B41]). LysR-family transcriptional regulators consist of two characteristic domains, an N-terminal HTH DNA binding domain (PF00126) and a C-terminal substrate binding domain (PF03466). There are two transcriptional regulators in *S. pneumoniae* that control the expression of the cysteine and methionine genes (CmhR and CmbR) ([@B37]). CmhR in *S. pneumoniae* belongs to the LysR family of transcriptional factors and has an HTH (helix-turn-helix) domain and a substrate binding domain of LysR-type transcriptional regulators (LTTRs). CmhR acts as a transcriptional activator of the *fhs*, *folD*, *metB*, *metEF*, *metQ*, and *spd-0431* genes and a 17-bp palindromic sequence (5′-TATAGTTTSAAACTATA-3′) is present in the promoter regions of CmhR-regulated genes in *S. pneumoniae* D39 ([@B1]). There are two methionine transport systems \[the methionine ABC uptake transporter (MUT)\] ([@B36]; [@B17]) and a secondary transporter BcaP ([@B10]) in bacteria. *metD* codes for the MUT system in *E. coli* and also have the MetQ substrate binding protein (SBP), MetL trans-membrane permease and the MetN cytoplasmic ATP hydrolyzing protein (ATPase) ([@B36]). The *spd-0150--54* locus codes for a methionine uptake ABC transporter in *S. pneumoniae* D39 and deletion of the gene encoding the lipoprotein MetQ resulted in a strain that had hampered growth in methionine-restricted medium and no measurable uptake of radioactive methionine ([@B6]). Furthermore, deletion of locus encoding MetEF (which is also part of the CmhR regulon) resulted in an increase in the growth defect of the *metQ* deletion strain in methionine-restricted medium and in blood plasma, reinforcing a role for the products of these genes in methionine synthesis ([@B6]). CmhR-regulated genes have important roles in the transport and biosynthesis of methionine. Csd and MetE are part of methionine synthesis pathway as Csd coverts cystathionine into homocysteine and MetE converts homocysteine into methionine ([@B20]). Cystathionine and homocysteine can also be formed from homoserine, where *O*-acetyl-[L]{.smallcaps}-homoserine is converted into cystathionine by MetB. *O*-acetyl-[L]{.smallcaps}-homoserine can also be converted into homocysteine by MetB and SPD-1073-74 (*spd-1073-1074* encode an *O*-acetylhomoserine aminocarboxypropyltransferase/cysteine synthase and a hypothetical protein, respectively) ([@B20]). Methionine can also be synthesized by other microbes as they may convert homoserine to homocysteine through addition of a sulfur group from either cysteine (involving MetABC), sulfide (involving MetA and CysD) or by using the SAM recycling pathway (MetK, Pfs and LuxS) ([@B25]). MetE (methionine synthase) then methylates homocysteine in combination with MetF (methylenetetrahydrofolate reductase) and 5-methyltetrahydrofolate (FolD) provides it with the methyl group to form methionine ([@B39]; [@B25]).

CmbR is the second one and acts as transcriptional repressor for *spd-0150*, *metEF*, *gshT*, *spd-0618*, *tcyB*, *metA*, and *yvdE*. The deletion of CmbR led to a significant increase in the activity of the CmbR-regulated promoters. Thus, it represents a different mode of regulation of the cysteine/methionine genes than in other related streptococci.

A number of metal-related genes are found to be differentially expressed in our tested conditions. These genes include *psaBC* and *prtA*, which belong to the PsaR regulon. *psaBCA* encode a Mn^2+^-dependent ABC transporter PsaBCA and *prtA* codes for a serine protease PrtA. The expression of these genes was also altered in our recent transcriptome of *S. pneumoniae* D39 grown in CDM with 0--10 mM methionine ([@B1]). The DtxR-family transcriptional regulator PsaR represses the expression of the PsaR regulon in the presence of Mn^2+^ ([@B19]). Zn^2+^, Ni^2+^ and Co^2+^ have been demonstrated to bind with PsaR and relieve the Mn^2+^-dependent repression of the PsaR regulon ([@B24]; [@B32],[@B33]). The interplay or competition of metal ions plays a significant role in the regulation of metal-responsive genes. Competition of Mn^2+^ with Zn^2+^, Co^2+^, or Ni^2+^ in the regulation of the PsaR regulon by transcriptional regulator PsaR has already extensively been studied in *S. pneumoniae* ([@B24]; [@B32],[@B33]). The significant changes in the expression of some of these metal-responsive genes in our study indicate the involvement of *S*-containing amino acids in this interplay as well, in an as yet unknown way.
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